Tag

Two Infinity Partners

5 articles
The minimal response to the open offer for Novartis India highlights challenges for WaveRise and ChrysCapital, backed by Two Infinity Partners, in acquiring a controlling stake. Despite a tender price of ₹860.64 per share and a recommended acceptance from the Independent Directors Committee, the offer has received virtually no shares, with only a handful tendered as of the latest updates. This subdued response suggests limited interest from public shareholders in selling their holdings, potentially complicating the acquirers' plans to secure the targeted 26% stake and full control of Novartis India. Investors should monitor whether tendering activity increases before the offer closes on June 24th, as a failure to secure the desired stake could impact the investment thesis.